Dept Menu

Audience Menu

 
Clinical recommendations

The Society of Family Planning places a high priority on developing methodologically rigorous, evidence-based clinical recommendations. These recommendations review the medical literature and should not be construed as prescribing exclusive courses of treatment or procedures relating to any clinical matter. Recommendations and guidelines developed or endorsed by SFP are subject to periodic revision as warranted by advancements in the field.

To suggest a topic for a future clinical recommendation, please contact Hannah Lange, Clinical Affairs Manager, at HLange@SocietyFP.org, 866.584.6758 ext. 404. 

 

Consensus guidelines for facilities performing outpatient procedures: evidence over ideology
American College of Obstetricians and Gynecologists and the National Partnership for Women & Families. Prepared by Barbara S. Levy, MD; Debra L. Ness, MS; and Steven E. Weinberger, MD. Published in Obstetrics & Gynecology 133(2)2019, pp. 255-260. (Endorsed August 2018)  

Contraception after surgical abortion
Prepared by Andrea Hsu Roe, MD, MPH, and Deborah Bartz, MD, MPH. Published in Contraception 99(1)2019, pp. 2-9. Guideline #2018-2. 

Pain control in surgical abortion part 1 — local anesthesia and minimal sedation
Prepared by Rebecca H. Allen, MD, MPH, and Rameet Singh, MD. Published in Contraception 97(6)2018, pp. 471-477. Guideline #2018-1.

Postplacental insertion of intrauterine devices
Prepared by Amy K. Whitaker, MD, and Beatrice A. Chen, MD, MPH. Published in Contraception 97(1)2018, pp. 2-13. Guideline #2017-2.

Use of intrauterine devices in nulliparous women
Prepared by Patricia A. Lohr, MD, Richard Lyus, BSc, MBBS, and Sarah Prager, MD, MAS. Published in Contraception 95:6(2017), pp. 529–537. Guideline #2017-1.

Medical abortion reporting of efficacy: the MARE guidelines
Prepared by Mitchell D. Creinin, MD, and Melissa J. Chen, MD. Published in Contraception 94:1(2016), pp. 97-103. Guideline #2016-1.

Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation) (This document revises and replaces the previous version, originally published in #2007-1)
Prepared by Rebecca H. Allen, MD, MPH, and Alisa B. Goldberg, MD, MPH. Published in Contraception 93:4(2015), pp. 277-291. Guideline #2015-1.

Medical management of first-trimester abortion
Prepared by the Committee on Practice Bulletins — Gynecology and the Society of Family Planning with the assistance of Mitchell D. Creinin, MD, and Daniel A. Grossman, MD. Published in Contraception 89(3)2014, pp. 148–161. Guideline #2014-1.

Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation (This document revises and replaces the previous version, originally published in #2007-2)
Prepared by Michelle C. Fox, MD, MPH and Colleen M. Krajewski, MD, MPH. Published in Contraception 89(2)2014, pp. 75-84. Guideline #2013-4.

Interruption of nonviable pregnancies of 24–28 weeks' gestation using medical methods
Prepared by Jamila B. Perritt, MD, MPH; Anne Burke, MD, MPH; and Alison B. Edelman, MD, MPH. Published in Contraception 88(3)2013, pp. 341-349. Guideline #20133.

Surgical abortion prior to 7 weeks of gestation
Prepared by E. Steve Lichtenberg, MD, MPH, and Maureen Paul, MD, MPH, with administrative assistance from Laura Dodge, MPH. Published in Contraception 88(1)2013, pp. 7-17. Guideline #20132.

Management of postabortion hemorrhage
Prepared by Jennifer Kerns, MD, MPH, and Jody Steinauer, MD, MAS. Published in Contraception 87(3)2013, pp. 331-342. Guideline #20131.

First-trimester abortion in women with medical conditions
Prepared by Maryam Guiahi, MD, MS, and Anne Davis, MD, MPH. Published in Contraception 86: 6(2012), pp. 622-630. Guideline #20122.

Cancer and contraception
Prepared by Ashlesha Patel, MD, MPH; E. Bimla Schwarz, MD, MS, with assistance from Mini Sreedevi, MD, and Alicia Roston, MPH. Published in Contraception 86:3(2012), pp. 191-198. Guideline #20121.

Labor induction abortion in the second trimester
Prepared by Lynn Borgatta, MD, MPH, and Nathalie Kapp, MD, MPH. Published in Contraception 84:1(2011), pp. 4-18. Guideline #20111.

Prevention of infection after induced abortion
Prepared by Sharon L. Achilles, MD, PhD and Matthew F. Reeves, MD, MPH. Published in Contraception 83:4(2011), pp. 295-309. Guideline #20102.

Induction of fetal demise before abortion
Prepared by Justin Diedrich, MD, and Eleanor Drey, MD, EdM. Published in Contraception 81:6(2010), pp. 462-473. Guideline #20101.

Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women
Prepared by Richard Lyus, MBBS, BSc.; Patricia Lohr, MD, MPH; and Sarah Prager,
MD, MAS. Published in Contraception 81:5(2010), pp. 367-371. Guideline #20092.

Contraceptive considerations in obese women
Prepared by Alison Edelman, MD, MPH. Published in Contraception 80:6(2009), pp. 583-590. Guideline #20091.

Cervical preparation for surgical abortion from 20 to 24 weeks’ gestation
Prepared by Sara Newmann, MD, MPH; Andrea Dalve-Endres, MD; and Eleanor A. Drey, MD, EdM. Published in Contraception 77:4(2008), pp. 308-314. Guideline #20073.


The Society of Family Planning website provides information on medical topics. However, the information is not intended to substitute for the advice of a physician or other licensed health care provider as they relate to any personal health matters. Unless otherwise specifically indicated, the naming of any organization, company, product, device or therapy on this site does not imply SFP endorsement.

Back to top